Close Menu

NEW YORK (GenomeWeb) — Clinical Genomics said today that its CLIA-licensed and CAP-accredited New Jersey laboratory has received licensure from California authorities to offer the Colvera colorectal cancer test to residents of the state.

Colvera is a PCR-based test for colorectal cancer recurrence monitoring. It measures methylation in circulating tumor DNA in a peripheral blood sample and can indicate the presence or absence of two altered genes associated with colorectal cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.